Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$558M |
| 2 |
Apple
AAPL
|
+$265M |
| 3 |
Microsoft
MSFT
|
+$209M |
| 4 |
Amazon
AMZN
|
+$197M |
| 5 |
Visa
V
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COHR
Coherent Inc
COHR
|
+$86.3M |
| 2 |
TSMC
TSM
|
+$77.2M |
| 3 |
iShares MBS ETF
MBB
|
+$44.5M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$43.8M |
| 5 |
Vale
VALE
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.97% |
| 2 | Financials | 12.67% |
| 3 | Consumer Discretionary | 11.32% |
| 4 | Healthcare | 10.27% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
State Street Financial Select Sector SPDR ETF
XLF
$58.4B
| $1.94M | ﹤0.01% |
52,817
-9,707
| -16% | -$355K |
|
|
FARO
477
DELISTED
Faro Technologies
FARO
| $1.92M | ﹤0.01% |
24,736
+314
| +1% | +$24.7K |
|
|
KYO
478
DELISTED
Kyocera Adr
KYO
| $1.9M | ﹤0.01% |
30,736
-347
| -1% | -$21.5K |
|
479
Progressive
PGR
$125B
| $1.89M | ﹤0.01% |
19,192
-1,504
| -7% | -$149K |
|
480
Pentair
PNR
$11.2B
| $1.88M | ﹤0.01% |
27,849
-67
| -0.2% | -$4.43K |
|
481
Amdocs
DOX
$6.28B
| $1.87M | ﹤0.01% |
24,187
-641
| -3% | -$49.5K |
|
482
EPAM Systems
EPAM
$4.86B
| $1.87M | ﹤0.01% |
3,651
-275
| -7% | -$129K |
|
483
Altria Group
MO
$113B
| $1.82M | ﹤0.01% |
38,168
-289
| -0.8% | -$14.2K |
|
484
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.8B
| $1.82M | ﹤0.01% |
32,260
+4,460
| +16% | +$240K |
|
485
Tyson Foods
TSN
$20.6B
| $1.74M | ﹤0.01% |
23,590
+731
| +3% | +$56.7K |
|
486
Korn Ferry
KFY
$4.2B
| $1.72M | ﹤0.01% |
23,703
-33
| -0.1% | -$2.19K |
|
|
REP
487
DELISTED
REPSOL YPF SA ADS(RP 1 CAP SH)
REP
| $1.71M | ﹤0.01% |
136,489
+4,305
| +3% | +$53.9K |
|
488
Target
TGT
$66.8B
| $1.7M | ﹤0.01% |
7,016
+3,057
| +77% | +$669K |
|
489
Invesco China Technology ETF
CQQQ
$3.17B
| $1.68M | ﹤0.01% |
19,995
-3,500
| -15% | -$284K |
|
490
Ameris Bancorp
ABCB
$5.92B
| $1.68M | ﹤0.01% |
33,187
-304
| -0.9% | -$16.3K |
|
491
SiteOne Landscape Supply
SITE
$4.3B
| $1.67M | ﹤0.01% |
+9,859
| New | +$1.72M |
|
492
Myriad Genetics
MYGN
$304M
| $1.64M | ﹤0.01% |
53,754
-324
| -0.6% | -$9.36K |
|
493
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.91B
| $1.6M | ﹤0.01% |
14,568
-101,500
| -87% | -$11.1M |
|
494
PetMed Express
PETS
$42.1M
| $1.56M | ﹤0.01% |
48,901
-13,096
| -21% | -$416K |
|
495
Novavax
NVAX
$1.27B
| $1.53M | ﹤0.01% |
7,198
-80
| -1% | -$14.7K |
|
496
Valero Energy
VLO
$87.2B
| $1.48M | ﹤0.01% |
18,934
+179
| +1% | +$13.9K |
|
497
iShares Core S&P 500 ETF
IVV
$897B
| $1.48M | ﹤0.01% |
3,434
+197
| +6% | +$82.5K |
|
498
Philip Morris
PM
$293B
| $1.46M | ﹤0.01% |
14,769
+204
| +1% | +$19.6K |
|
|
ANSS
499
DELISTED
Ansys
ANSS
| $1.45M | ﹤0.01% |
4,184
-365
| -8% | -$126K |
|
500
Zimmer Biomet
ZBH
$18.8B
| $1.45M | ﹤0.01% |
9,281
+853
| +10% | +$138K |
|
Similar funds
Ken Fisher's Q2 2021 Portfolio in Review
As of Q2 2021, Ken Fisher held 1,100 positions worth $159B, up 12% from $142B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Fisher deployed $4.92B of net new capital in Q2 2021, opening 101 new positions and adding to 388 existing holdings. Its largest new stake was Organon & Co: 967,460 shares worth $29.3M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was TSMC, an estimated $77.2M trimmed.
- Ken Fisher's largest Q2 2021 buy was Organon & Co: 967,460 shares worth $29.3M.
- Ken Fisher added most to Vanguard Intermediate-Term Corporate Bond ETF in Q2 2021, an estimated $558M increase.
- Ken Fisher's biggest Q2 2021 reduction was TSMC, cutting an estimated $77.2M.
- Ken Fisher fully exited Coherent Inc in Q2 2021, selling an estimated $86.3M.
- Ken Fisher's ten largest holdings make up 32% of its $159B portfolio in Q2 2021.
- Ken Fisher opened 101 new positions and closed 90 in Q2 2021.
- Ken Fisher's portfolio value rose 12% quarter-over-quarter to $159B.
Based on Fisher Asset Management's 13F filing for Q2 2021, filed 27 Jul 2021.